Position in AVXL
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$847,820
-$157,740 QoQ
Shares Held
327,344
-0.1% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1
of 4 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 1.4550442348110857.ToString("F0")%
Shared 0.ToString("F0")%
None 98.54495576518892.ToString("F0")%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PVG ASSET MANAGEMENT CORP holds $3,151,080 across 9 Biotechnology names. AVXL ranks #1 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
This page
|
327,344 | $847,820 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
19,818 | $773,100 | |
| 3 | IMRX |
Immuneering Corp
|
146,451 | $730,790 | |
| 4 | MDWD |
MediWound Ltd.
|
18,122 | $266,393 | |
| 5 | ALT |
Altimmune, Inc.
|
66,120 | $201,004 | |
| 6 | CHRS |
Coherus Oncology, Inc.
|
133,235 | $186,529 | |
| 7 | ARDX |
Ardelyx, Inc.
|
11,393 | $58,104 | |
| 8 | MAIA |
MAIA Biotechnology, Inc.
|
34,135 | $49,154 |
All Filings in AVXL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $847,820 | 327,344 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $1,005,560 | 327,544 | Shares | Sole | 2026-06-16 | |
| 2025-12-31 | $770,010 | 216,295 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,185,017 | 133,148 | Shares | Sole | 2025-12-31 | |
| 2025-06-30 | $1,027,522 | 111,445 | Shares | Sole | 2025-09-02 | |
| 2025-03-31 | $708,776 | 82,608 | Shares | Sole | 2025-06-04 | |
| 2024-12-31 | $842,982 | 78,490 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $73,868 | 13,005 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||